Results for intravenous translation from Danish to English

til intravenous anvendelse.
for intravenous use.

busulfan (intravenous use)
busulfan (intravenous use)

subkutan eller intravenous anvendelse
subcutaneous or intravenous use

intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation
intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation

guidelines note for guidance on the clinical investigation of human anti- d immunoglobulin for intravenous and/ or intramuscular use
emea/cpmp/bpwg/575/99

vigtige oplysninger om nogle af indholdsstofferne i cerezyme dette lægemiddel indeholder natrium og gives i 0, 9% natriumklorid intravenous opløsning (se pkt.6. 6) .
important information about some of the ingredients of cerezyme this medicinal product contains sodium and is administered in 0.9% sodium chloride intravenous solution.

guidelines note for guidance on the clinical investigation of human anti-d immunoglobulin for intravenous and/or intramuscular use note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (ivig) core spc for human and anti-d immunoglobulin for intravenous and/or intramuscular use core spc for human normal immunoglobulin for intravenous administration (ivig) core spc for human plasma derived and recombinant coagulation factor viii products core spc for human plasma derived and recombinant coagulation factor ix products note for guidance on the clinical investigation of human plasma derived factor viii and ix products note for guidance on the clinical investigation of recombinant factor viii and ix products
note for guidance on the clinical investigation of human anti-d immunoglobulin for intravenous and/or intramuscular use adopted june 2000 note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (ivig) adopted june 2000 core spc for human and anti-d immunoglobulin for intravenous and/or intramuscular use adopted june 2000 core spc for human normal immunoglobulin for intravenous administration (ivig) adopted june 2000 core spc for human plasma derived and recombinant coagulation factor viii products adopted june 2000 core spc for human plasma derived and recombinant coagulation factor ix products adopted june 2000 note for guidance on the clinical investigation of human plasma derived factor viii and ix products adopted october 2000 note for guidance on the clinical investigation of recombinant factor viii and ix products adopted october 2000